ABSTRACT OBJECTIVES This study sought to evaluate the self-expandable ACURATE TA device (Symetis SA, Ecublens, Switzerland) in a cohort of patients with pure aortic regurgitation (AR).
T ranscatheter aortic valve replacement (TAVR) has been well established in the treatment of high-risk patients presenting with aortic valve stenosis and has changed the paradigms in the treatment of aortic valve stenosis (1, 2) .
The original concept of this technique is based in principle on implanting an oversized balloon-or self-expandable transcatheter heart valve (THV) into the calcified native aortic annulus (3) . As a result, aortic calcification is presumably essential for stable fixation of the stent frame. This follows from the fact that pure, severe aortic regurgitation (AR) has been considered a relative contraindication to TAVR due to the absence of aortic calcification.
The purpose of the present study was therefore to Transesophageal echocardiography. Detailed transesophageal echocardiography (TEE) was performed before TAVR. Two-dimensional TEE was performed with the use of a standard Philips i33 ultrasound system with a multiplane (X7-2t) matrix-array probe (Philips Medical Systems). The probe consists of a transducer that provides high-resolution images and operates at broadband frequencies ranging between 2 and 7 MHz. Pre-procedural TEE was performed after administration of topical anesthesia of the pharynx and application of intravenous sedation (midazolam), after which the probe was introduced into the esophagus. Using the short-axis view, the opening of the insufficient aortic valve was captured, and the highest quality loops were viewed and evaluated after acquisition as described in the following. The aortic annulus diameter was measured by using the 3-chamber long-axis view at an w120 angle. The diameter was measured as the largest possible diameter during systole using the inner edge to inner edge as recommended (4, 5) .
FOLLOW-UP ECHOCARDIOGRAPHIC EXAMINATIONS.
All patients underwent a detailed pre-procedural transthoracic echocardiography (TTE) and TEE exam- Wendt et al.
cardiac surgeons, cardiologists, anesthesiologists, and perfusionists, provided optimal support during the TAVR procedure. Transapical access was performed as previously described by our group (7) using 4 pledged-armed U-stitches (Prolene 3-0, MH needle).
However, in contrast to our standard TAVR protocol, intraprocedural preparatory balloon aortic valvuloplasty was not performed due to the absence of aortic calcification, and, moreover, all valve implantations were done without rapid pacing. Self-expandable ACURATE TA bioprosthesis (Symetis SA, Ecublens, Switzerland).
Wendt et al. Table 2 , and clinical and safety outcomes according to VARC-2 in Table 3 . Wendt et al. Table 4 shows the 3-to 6-month echocardiographic follow-up. Essen, Germany. E-mail: daniel.wendt@uk-essen.de.
